Pritom Chowdhury

Dr. Pritom Chowdhury

Tea Research Association, Tocklai Tea Research Institute, Jorhat 785 008, Assam, India

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
DSDevojit Kumar Sarma
Devojit Kumar Sarma
RDRuchi Dubey
Ruchi Dubey
Ravindra M SamarthRavindra M Samarth
Ravindra M Samarth
SSSwasti Shubham
Swasti Shubham
PCPritom Chowdhury
Pritom Chowdhury
MKMANOJ KUMAR
MANOJ KUMAR
Environmental exposure to microplastics (MPs) and nanoplastics (NPs) is an increasing concern from human health perspectives. Little information on the genotoxic and cytotoxic potential of NP particles in human cells is available. We aimed to assess the cytotoxic and genotoxic potential of polystyrene nanoplastics (PSNPs) at different concentrations (2000μg/mL, 1000μg/mL, and 500μg/mL) by using chromosomal aberration (CA) and cytokinesis-block micronucleus assays (CBMN) on human peripheral lymphocytes. Dose-dependent hemolytic activity and cell viability were observed against the PSNPs exposure. Increased chromosomal aberrations, such as chromosomal breaks and dicentric chromosomes, and an increase in nucleoplasmic bridge (NBP) formation and nuclear budding (NBUD) were observed. The frequency of mitotic index (MI) decreased significantly in the PSNP-exposed groups from lower to higher concentrations. A significant increase in micronuclei (MN) formation and cytostasis% and a dose-dependent reduction in nuclear division index (NDI) in PSNP-exposed groups indicated oxidative stress-mediated cytotoxicity, DNA damage, and genomic instabilities due to PSNP exposure in human lymphocyte cells. This study highlights the importance of understanding the toxic mechanisms and associated chronic and acute health effects on humans due to exposure to this pervasive environmental pollutant.

28 October 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
PCPritom Chowdhury
Pritom Chowdhury
ABAnoop Kumar Barooah
Anoop Kumar Barooah
Innate immunity impairment led to disruption in cascade of signaling pathways upregulating pro-inflammatory cytokines, diminish interferons, depleted natural killer cells and activate reactive oxygen species production. These conditions severely affected body’s ability to fight against infectious diseases and also plays a pivotal role in disease progression. Here, in emphasis is on nutritional immunity for regulating effective innate immune response for combating against infectious diseases like novel coronavirus disease (COVID 19). Drawing from discoveries on in-vitro experiments, animal models and human trials, tea polyphenols, micronutrients, and vitamins has the potential to modulate and enhance innate immune response. This article provides a comprehensive review on tea (Camellia sinensis L) infusion (a hot water extract of dried processed tea leaves prepared from young shoots of tea plant) as an innate immunity modulator. Tea infusion is rich in polyphenols; epigallocatechin gallate (EGCG) and theaflavin (TF), major green and black tea polyphenols, respectively. Studies showed their immunomodulatory competence. Tea infusions are also rich in alkaloids; caffeine and its intermediates, theophylline and theobromine, which have anti-inflammatory properties. Tea plant being an acidophilic perennial crop can accumulate different micronutrients, viz., copper (Cu), iron (Fe), manganese (Mn), selenium (Se), and zinc (Zn) from growing medium, i.e., from soil, which led to their considerable presence in tea infusion. Micronutrients are integral part of innate immune response. Overall, this review presents tea infusion as an important source of nutritional immunity which can enhance innate immune response in order to mitigate the unprecedented COVID-19 pandemic.

10 March 2021 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
MGMadhurjya Gogoi
Madhurjya Gogoi
MBMeghali Borkotoky
Meghali Borkotoky
SBSangeeta Borchetia
Sangeeta Borchetia
PCPritom Chowdhury
Pritom Chowdhury
SMSaurov Mahanta
Saurov Mahanta
ABAnoop Kumar Barooah
Anoop Kumar Barooah
The global pandemic due to the novel Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) has taken more than a million lives. Lack of definitive vaccine/drugs against this highly contagious virus has accelerated exploratory research on novel natural and synthetic inhibitors. Tea is a rich source of bioactives and known to have antiviral properties. In this study, an in silico strategy involving ADMET property screening, receptor–ligand docking and molecular dynamic (MD) simulation was employed to screen potential tea bio-active inhibitors against three selected targets (RdRp, 3CLpro and PLpro) of SARS-CoV-2. Among the 70 tea bioactives screened, theaflavin 3,3’-di-gallate (TF3), Procyanidin B2 and Theaflavin 3-gallate (TF2a) exhibited highest binding affinities towards RdRp, 3CLpro/Mpro and PLpro targets of SARS-CoV-2 with low docking scores of −14.92, −11.68 and −10.90 kcal/mol, respectively. All of them showed a substantial number of hydrogen bonds along with other interactions in and around the active sites. Interestingly, the top bioactives in our study showed higher binding affinities compared with known antiviral drugs. Further, the top protein–ligand complexes showed less conformational changes during binding when subjected to MD simulation for 100 nanoseconds. The MMPBSA results revealed that RdRp-TF3, 3CLpro-Procyanidin B2 and PLpro-TF2a complexes were stable with binding free energies of −93.59 ± 43.97, −139.78 ± 16.51 and −96.88 ± 25.39 kJ/mol, respectively. Our results suggest that theaflavin 3,3’-digallate, Theaflavin 3-gallate and Procyanidin B2 found in black tea have the potential to act as inhibitors for selected targets of SARS-CoV-2 and can be considered as drug candidates in future studies against COVID-19. Graphical Abstract Communicated by Ramaswamy H. Sarma

2 May 2017 in Environmental Chemistry Letters
Verified
Journal Article
Closed access
PDF file
PCPritom Chowdhury
Pritom Chowdhury
MGMadhurjya Gogoi
Madhurjya Gogoi
SBSangeeta Borchetia
Sangeeta Borchetia
TBTanoy Bandyopadhyay
Tanoy Bandyopadhyay

1 January 2014 in Comparative Immunology, Microbiology and Infectious Diseases
Verified
Journal Article
Closed access
PCPritom Chowdhury
Pritom Chowdhury
Siraj Ahmed KhanSiraj Ahmed Khan
Siraj Ahmed Khan
PDPrafulla Dutta
Prafulla Dutta
RTRashmee Topno
Rashmee Topno
JMJagadish Mahanta
Jagadish Mahanta

17 May 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
PCPritom Chowdhury
Pritom Chowdhury
MSMarie-Emmanuelle Sahuc
Marie-Emmanuelle Sahuc
YRYves Rouillé
Yves Rouillé
AVAlexandre Vandeputte
Alexandre Vandeputte
PBPriscille Brodin
Priscille Brodin
KSKarin Séron
Karin Séron
The treatment of hepatitis C virus (HCV) infection by combination of direct acting antivirals (DAA), with different mode of action, has made substantial progress in the past few years. However, appearance of resistance and high cost of the therapy is still an obstacle in the achievement of the therapy, more specifically in developing countries. In this context, search for affordable antivirals with new mechanisms of action is still needed. Tea, after water, is the most popular drink worldwide. Polyphenols extracted from green tea have already shown anti-HCV activity as entry inhibitors. Here, three different theaflavins, theaflavin (TF1), theaflavin-3’-monogallate (TF2), and theaflavin-3-3’-digallate (TF3), which are major polyphenols from black tea, were tested against HCV in cell culture. The results showed that all theaflavins inhibit HCV infection in a dose-dependent manner in an early step of infection. Results obtained with HCV pseudotyped virions confirmed their activity on HCV entry and demonstrated their pan-genotypic action. No effect on HCV replication was observed by using HCV replicon. Investigation on the mechanism of action of black tea theaflavins showed that they act directly on the virus particle and are able to inhibit cell-to-cell spread. Combination study with inhibitors most widely used in anti-HCV treatment regimen demonstrated that TF3 exerts additive effect. In conclusion, theaflavins, that are present in high quantity in black tea, are new inhibitors of HCV entry and hold promise for developing in therapeutic arsenal for HCV infection.